Scribe Biosciences

📍 San Francisco, United States🗓 Founded 2017👥 8 employees💰 Last funded 2021
Biotechnology Research🌐 scribebiosciences.com
Website LinkedIn
Scribe Biosciences is an early-stage company pioneering technologies to accelerate immunotherapy discoveries through linked functional and genomic profiling of single-cell interactions.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Scribe Biosciences?
Scribe Biosciences has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Scribe Biosciences last raise funding?
The most recent investment in Scribe Biosciences recorded on gritt.io was in 2021.
When was Scribe Biosciences founded?
Scribe Biosciences was founded in 2017.
What industry is Scribe Biosciences in?
Scribe Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Scribe Biosciences based?
Scribe Biosciences is headquartered in San Francisco, United States.